AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
P/E ratio for AquaBounty Technologies, Inc. (AQB)
P/E ratio as of 2023: -0.40
According to AquaBounty Technologies, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.40. At the end of 2022 the company had a P/E ratio of -2.47.
P/E ratio history for AquaBounty Technologies, Inc. from 2005 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -0.40 |
| 2022 | -2.47 |
| 2021 | -6.41 |
| 2020 | -19.24 |
| 2019 | -3.27 |
| 2018 | -2.57 |
| 2017 | -3.34 |
| 2016 | -16.58 |
| 2015 | -18.98 |
| 2014 | -17.39 |
| 2013 | -22.71 |
| 2012 | -18.94 |
| 2011 | -446.79 |
| 2010 | -182.09 |
| 2009 | -183.65 |
| 2008 | -132.80 |
| 2007 | -128.49 |
| 2006 | -95.43 |
| 2005 | -29.40 |